Ovation Science Inc. (CSE:OVAT)

Revenue by Product

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Royalty	33.74K
Royalty Growth	-73.73%
Topical and Transdermal Cannabis Products	28.19K
Topical and Transdermal Cannabis Products Growth	189.65%

Revenue by Geography

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Canada	33.74K
Canada Growth	2690.90%
United States	28.19K
United States Growth	-79.41%